EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan–Kynurenine Metabolic Pathway

Donglin Guo, Jiayong Xie iD, Xueyun Dong iD, Hao Xu iD, Yunhan Xie iD, Xinyu Liu iD, Linlin Xu iD, Asmaa Ali iD, Min Chen iD, Leilei Zhang iD, Jiayuan He iD, Liang Wu iD und 1 weitere

Journal of Immunology Research · 2026

DOI: 10.1155/jimr/1020462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Donglin Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory of Shanxi Provincial People's Hospital, Taiyuan 030012, China. Hauptthemen laut MEDLINE: Xanthophylls, Tryptophan, Diabetic Nephropathies, Kynurenine. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Provincial Basic Research Program-Young Scientists Research Project, Taizhou Science and Technology Support Program (Social Development) Project, Scientific Research Project of Yancheng Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study employs a multiomics approach to investigate the protective effects of fucoxanthin (Fu) and explore its potential association with metabolic and signaling pathways in diabetic mice induced by a high‐fat diet combined with streptozotocin (STZ) administration. Diabetic model mice were randomly divided into normal control (NC), diabetic model, low‐dose Fu (50 mg/kg/day), and high‐dose Fu (100 mg/kg/day) groups. After 6 weeks of intervention, Fu treatment was associated with dose‐dependent improvements in glucose and lipid metabolism, reduced oxidative stress, decreased expression of inflammatory cytokines (tumor necrosis factor‐α [TNF‐α], interleukin‐6 [IL‐6], and IL‐1β) and renal fibrosis markers (TGF‐β1, α‐SMA, and Col1a1), along with notable attenuation of renal pathological damage. Exploratory analyses indicated that these phenotypic improvements were accompanied by reduced renal IDO1 expression, favorable shifts in tryptophan (Trp) metabolism, and upregulated AhR/CYP1A1 signaling. 16S rRNA sequencing revealed that Fu treatment was associated with a restoration of diabetes‐altered gut microbiota β‐diversity. Serum metabolomics identified that Fu administration correlated with alterations in multiple metabolites (including 5′‐S‐methyl‐5′‐thioadenosine, LPC 16:0, and bile acids), which are linked to key pathways such as Trp metabolism and bile acid biosynthesis. Network pharmacology predictions further suggested potential multitarget interactions of Fu with the PI3K‐Akt and AGE‐RAGE signaling pathways. Collectively, these findings indicate that Fu exerts potential renoprotective effects in diabetic mice, which are accompanied by a normalization of Trp–AhR pathway‐related metabolism and concurrent attenuation of inflammatory, oxidative, and fibrotic responses. While causal functional links remain to be fully elucidated, these observations provide a preliminary basis for further mechanistic investigation and support the potential of Fu as a dietary supplement or adjunctive strategy for diabetic kidney disease (DKD).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XanthophyllsTryptophanDiabetic NephropathiesKynurenineGastrointestinal MicrobiomeDiabetes Mellitus, ExperimentalAnimalsMiceMaleOxidative StressSignal TransductionMetabolic Networks and PathwaysKidneyHumansMetabolomicsDisease Models, AnimalCytokinesDiet, High-Fat

Stichwörter der Autor:innen

diabetic kidney diseasefucoxanthingut microbiotakynurenineoxidative stresstryptophan metabolism

Substanzen

XanthophyllsTryptophanfucoxanthinKynurenineCytokines

Autor:innen und Institutionen

  • Clinical Laboratory of Shanxi Provincial People's Hospital, Taiyuan 030012, China.
  • Nephrology Department, Xinghua People's Hospital Affiliated to Yangzhou University, Taizhou 225700, China.
  • School of Medicine, Jiangsu University, Zhenjiang 212013, China, ujs.edu.cn.
  • Department of Laboratory Medicine, The First People's Hospital of Yancheng, Yancheng 224000, China.
  • Department of Pulmonary Medicine, Abbassia Chest Hospital, EMOH, Cairo 11517, Egypt.
  • Public Experiment and Service Center, Jiangsu University, Zhenjiang 212013, China, ujs.edu.cn.

ORCID-Profile: Jiayong Xie, Xueyun Dong, Hao Xu, Yunhan Xie, Xinyu Liu, Linlin Xu, Asmaa Ali, Min Chen, Leilei Zhang, Jiayuan He, Liang Wu, Keke Shao

Förderung

  • Shanxi Provincial Basic Research Program-Young Scientists Research Project
  • Taizhou Science and Technology Support Program (Social Development) Project
  • Scientific Research Project of Yancheng Municipal Health Commission
  • Jiangsu University 2023 Medical Education Collaborative Innovation Fund Project

Zitieren

APA

Guo, D., Xie, J., Dong, X., Xu, H., Xie, Y., Liu, X., Xu, L., Ali, A., Chen, M., Zhang, L., He, J., Wu, L., & Shao, K. (2026). Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan–Kynurenine Metabolic Pathway. Journal of Immunology Research. https://doi.org/10.1155/jimr/1020462

Vancouver

Guo D, Xie J, Dong X, Xu H, Xie Y, Liu X, et al. Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan–Kynurenine Metabolic Pathway. Journal of Immunology Research. 2026. doi:10.1155/jimr/1020462

BibTeX
@article{Guo2026,
  author = {Guo, Donglin and Xie, Jiayong and Dong, Xueyun and Xu, Hao and Xie, Yunhan and Liu, Xinyu and Xu, Linlin and Ali, Asmaa and Chen, Min and Zhang, Leilei and He, Jiayuan and Wu, Liang and Shao, Keke},
  title = {Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan–Kynurenine Metabolic Pathway},
  journal = {Journal of Immunology Research},
  year = {2026},
  doi = {10.1155/jimr/1020462}
}
Kostenlos starten →